Following this, we incorporated TRIM67 expression data, general clinical information, postoperative pathology, and US-related characteristics and screened six variables (stage, TRIM67, tumor size, N, age, and HER2 status) with the SVM–RFE method, which could predict the likelihood of tumor metastasis. Here, ERBB2 is linked to neoplasm.